KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to -$32.47.

  • Novavax's Times Interest Earned fell 264.03% to -$32.47 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.65, marking a year-over-year increase of 16969.4%. This contributed to the annual value of -$12.4 for FY2024, which is 6844.56% up from last year.
  • Novavax's Times Interest Earned amounted to -$32.47 in Q3 2025, which was down 264.03% from $18.32 recorded in Q2 2025.
  • In the past 5 years, Novavax's Times Interest Earned ranged from a high of $90.08 in Q1 2025 and a low of -$160.56 during Q4 2021
  • For the 5-year period, Novavax's Times Interest Earned averaged around -$29.03, with its median value being -$35.23 (2024).
  • As far as peak fluctuations go, Novavax's Times Interest Earned plummeted by 105812.76% in 2021, and later surged by 35568.3% in 2025.
  • Over the past 5 years, Novavax's Times Interest Earned (Quarter) stood at -$160.56 in 2021, then skyrocketed by 66.99% to -$53.01 in 2022, then grew by 15.88% to -$44.59 in 2023, then surged by 61.24% to -$17.28 in 2024, then plummeted by 87.91% to -$32.47 in 2025.
  • Its last three reported values are -$32.47 in Q3 2025, $18.32 for Q2 2025, and $90.08 during Q1 2025.